Joint Action

On this episode of Joint Action, Vicky puts David in the hot seat with listener questions—and a few personal ones too. RELATED EPISODES A chat to David and listener questions (2021) CONNECT WITH US Join one of our trials https://www.osteoarthritisresearch.com.au/current-trials Instagram: @ProfDavidHunter Twitter: @ProfDavidHunter @jointactionorg Email: [email protected] Website: www.jointaction.info/podcast If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

Ever wonder what is involved in a total hip replacement? On this week's episode of Joint Action, we are joined by Robyn Pulman. An avid listener of Joint Action, she now joins as a guest to share her lived experience with osteoarthritis and her personal journey through a recent left anterior hip replacement. Robyn is a public speaking and corporate communication coach and expert behind Speak for Impact , a platform dedicated to helping individuals and team communicate with clarity, confidence and influence. CONNECT WITH US Join one of our trials https://www.osteoarthritisresearch.com.au/current-trials Instagram: @ProfDavidHunter Twitter: @ProfDavidHunter @jointactionorg Email: [email protected] Website: www.jointaction.info/podcast If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

From reducing air pollution and greenhouse gas emissions to lowering rates of chronic disease and promoting mental well-being, active transport systems are reshaping cities and lives. On this week's episode of Joint Action, we are joined by Professor Adam Millard-Ball to explore how communities are reimagining streets to prioritise people over cars. Adam Millard-Ball is a professor of urban planning at the UCLA Luskin School of Public Affairs where he also directs the UCLA Institute of Transportation Studies. His research addresses the challenges of transportation and climate change by how we plan our streets and move around our cities and to identify and evaluate policies to reduce greenhouse gas emissions. RESOURCES Journal articles Global health and climate benefits from walking and cycling infrastructure CONNECT WITH US Join one of our trials https://www.osteoarthritisresearch.com.au/current-trials Instagram: @ProfDavidHunter Twitter: @ProfDavidHunter @jointactionorg Email: [email protected] Website: www.jointaction.info/podcast If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

Can two wheels really help ease joint pain? On this week's episode we are joined by Professor Tom Wainwright to discuss the benefits of cycling for hip osteoarthritis. He also discusses the findings of his recently completed randomised controlled trial comparing a cycling and educational intervention to usual physiotherapy care. Professor Tom Wainwright is a physiotherapist specialising in orthopaedic physiotherapy, researcher and educator. He has authored over 150 peer-reviewed publications is recognised as an international expert in Enhanced Recovery After Surgery (ERAS) protocols in Orthopaedics and was the lead author of the first ERAS Society guidelines for hip and knee replacement. Tom is passionate about improving the quality of healthcare systems and works to help other healthcare providers improve the quality of their services through teaching and consultancy. RESOURCES ORI Education App - ORI Education shares online learning courses to those with an interest in osteoarthritis and orthopaedic surgery. These courses are informed by the latest research and professional thinking from our institute, along with research evidence from across the globe. CHAIN (Cycling against Hip pAIN) Journal Articles Clinical and cost-effectiveness of a cycling and education intervention versus usual physiotherapy care for the treatment of hip osteoarthritis in the UK (CLEAT): a pragmatic, randomised, controlled trial CONNECT WITH US Join one of our trials https://www.osteoarthritisresearch.com.au/current-trials Instagram: @ProfDavidHunter Twitter: @ProfDavidHunter @jointactionorg Email: [email protected] Website: www.jointaction.info/podcast If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

Did you know that 1 in 8 Australians live with osteoarthritis? It is one of the leading causes of pain and disability worldwide. On this special episode, we hear from previous guests on common misconceptions and beliefs about osteoarthritis, the importance of staying physically active, behaviour change, and driving change in osteoarthritis. If you are interested, you can listen to the full episodes: “Common Misconceptions and Beliefs about Osteoarthritis” with A/Prof Ben Darlow (Season 6, Ep. 16) “Walking for Joint Health” with Dr Sarah Kobayashi (Season 6, Ep. 12) "Tips for behaviour change for diet and exercise" with Dr Shannon Mihalko (Season 4, Ep. 1) "Driving change in osteoarthritis - strategies, barriers and consumer power" with Louise Hardy (Season 6, Ep. 7) RESOURCES MyOA.org.au - Additional resources CONNECT WITH US Join one of our trials https://www.osteoarthritisresearch.com.au/current-trials Instagram: @profdavidhunter Twitter: @ProfDavidHunter @jointactionorg Email: [email protected] Website: www.jointaction.info/podcast If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

High tibial osteotomy (HTO) is a limb realignment surgery which is intended for people who have medial compartment osteoarthritis (OA), but are not suitable candidates for total knee replacement due to younger age, less severe disease and greater physical demands. The aim of HTO is to correct alignment, thereby shifting load away from the more involved knee compartment and limit progression of knee OA. On this week's episode of Joint Action, we are joined by Dr Trevor Birmingham and Dr David Parker to discuss high tibial osteotomy surgery, who it is suitable for and the risks involved. Professor Trevor Birmingham is a physiotherapist and Canada Research Chair in Musculoskeletal Rehabilitation at the University of Western Ontario in London, Canada. He leads research on musculoskeletal health, often combining clinical outcomes with biomechanical, imaging and biological measures in cohort studies and randomized trials. He co-directs the Wolf Orthopaedic Biomechanics Lab at the Fowler Kennedy Sport Medicine Clinic and is a founding member of the Bone and Joint Institute and the Collaborative Graduate Training Program in Musculoskeletal Health Research at Western University. Dr David Parker is an experienced orthopaedic knee specialist and co-founder of the Sydney Orthopaedic Research Institute (SORI). He is passionate about sport and is actively involved with international orthopaedic and sports medicine organisations and has extensive experience with athletes of all levels from recreational to elite. Dr Parker has authored over 100 peer-reviewed publications and many textbook chapters and has been awarded the Australian Orthopaedic Association Prize for Research. RESOURCES Journal articles Total knee replacement after high tibial osteotomy: time-to-event analysis and predictors CONNECT WITH US Join one of our trials https://www.osteoarthritisresearch.com.au/current-trials Twitter: @ProfDavidHunter @jointactionorg Email: [email protected] Website: www.jointaction.info/podcast If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

This week's episode is in honour of Frank Beier, who recently passed away on July 18, 2025. Frank leaves behind a remarkable legacy through the impact he made in the field of osteoarthritis. In this previous episode (2021), he discussed the recent advances in osteoarthritis understanding with a particular emphasis on novel targets and epigenetics. Despite the large prevalence of osteoarthritis, there is no clinically approved drug which provides a cure. Currently, drugs focus on relieving symptoms such as pain. Experiments done in the laboratory have provided insight on osteoarthritis onset and progression and will likely guide therapeutic development. We know that osteoarthritis is a disease of the whole organ meaning that any of the tissues involved in the synovial joint can be affected. The interplay between the various cell types involved is complex and understanding the interactions between cartilage, bone and synovium may be critical to therapeutic development. Skeletal development likely plays a very important role in predisposition to disease. Through the identification of serious pathologies such as various forms of dwarfism (what in medical terms are called chondrodysplasias) the role of transcription factors and epigenetics is increasing our understanding of disease genesis.The study of the epigenetics of OA - the mechanism by which the human genome alters it’s gene expression (without changing the primary DNA sequence) has provided valuable information on novel risk factors for the disease and are potential therapeutic targets for OA. RESOURCES Journal articles Nuclear receptors as potential drug targets in osteoarthritis Interplay between genetics and epigenetics in osteoarthritis Recent developments in emerging therapeutic targets of osteoarthritis CONNECT WITH US Twitter: @ProfDavidHunter @jointactionorg Email: [email protected] Website: www.jointaction.info/podcast If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

On this week's episode of Joint Action discover how ultra-processed foods may be silently contributing to osteoarthritis. Dr Gabby Joseph joins us to discuss her research research linking poor diet quality to greater knee pain, poorer physical function and thinner knee cartilage. Dr Gabby Joseph is a scientist and statistician with over 20 years of experience leading research funded by the US government at the University of California San Francisco, Her work focuses on musculoskeletal imaging, predictive modelling, and clinical study design, with a focus on applying advanced statistical and machine learning methods to improve patient outcomes She is the co-Director of The University of California's Clinical & Translational Musculoskeletal Imaging group and passionate about making sense of complex data so that it can be used to improve real-world care. RESOURCES Ultra-processed food consumption is associated with knee osteoarthritis: Data from the Osteoarthritis Initiative CONNECT WITH US Twitter: @ProfDavidHunter @jointactionorg Instagram: @osteoarthritisresearchgroup Email: [email protected] Website: www.jointaction.info/podcast Hosted on Acast. See acast.com/privacy for more information.

Dribbling into discovery - on this episode of Joint Action, we are joined by Dr John Drazan to learn more about how he is using basketball to inspire the next generation of scientists. Dr John Drazan is an Assistant Professor of biomedical engineering at Fairfield University where he studies the relationship between muscle structure and function to understand how muscles remodel in response to aging, injury, or training. He is an award-winning STEM educator and former collegiate basketball player who runs STEM focused clinics to encourage student interest in maths, science, technology and engineering. His innovative programs have reached over 25,000 students across the USA. CONNECT WITH US Twitter: @ProfDavidHunter @jointactionorg Instagram: @osteoarthritisresearchgroup Email: [email protected] Website: www.jointaction.info/podcast If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

Did you know your beliefs about osteoarthritis could be making your symptoms worse? In this re-aired episode from Season 5, Episode 1 of Joint Action, physiotherapist and health communication expert Dr Ben Darlow joins us to explore how common misconceptions - like “wear and tear” or “bone on bone” - can limit your activity and shape your treatment choices. We discuss the power of language, the importance of hope, and how better understanding can help you take control of your health. Whether you're living with osteoarthritis, supporting someone who is, or working in healthcare, this conversation is a must-listen. RESOURCES Living with osteoarthritis is a balancing act: an exploration of patients' beliefs about knee pain The osteoarthritis knowledge scale CONNECT WITH US Twitter: @ProfDavidHunter @jointactionorg Email: [email protected] Website: www.jointaction.info/podcast If you enjoyed this episode, don't forget to subscribe to learn more about osteoarthritis from the world's leading experts! And please let us know what you thought by leaving us a review! Hosted on Acast. See acast.com/privacy for more information.

Methotrexate is a well-established drug used in oncology, but could it also play a role in managing osteoarthritis? In this episode of Joint Action, Professor David Hunter is joined by Dr Anna Døssing and Professor Robin Christensen to explore the potential of methotrexate as a treatment for osteoarthritis pain. They discuss: What methotrexate is and how it works Insights from a recent meta-analysis on its effectiveness and safety Why individual studies show mixed results Whether it might help people with hand or knee OA - especially those with signs of inflammation How dosing and side effects factor into clinical decision-making Tune in for an honest, data-driven conversation about repurposing an old drug for a new purpose - and what it could mean for people living with osteoarthritis. RESOURCES Editorial: Methotrexate for osteoarthritis—Ready for clinical use and in whom?: https://www.oarsijournal.com/article/S1063-4584(25)00973-2/abstract? CONNECT WITH US Twitter: @ProfDavidHunter @jointactionorg Instagram: @osteoarthritisresearchgroup Email: [email protected] Website: https://www.jointaction.info/podcast Hosted on Acast. See acast.com/privacy for more information.

Metformin is one of the world’s most prescribed drugs for type 2 diabetes - but could it also help with knee osteoarthritis? In this episode of Joint Action, Prof. David Hunter is joined by Prof. Flavia Cicuttini to unpack the results of a groundbreaking clinical trial that tested metformin as a new treatment for knee pain in people with knee osteoarthritis. Tune in to hear what the study found, how the drug works, who might benefit, and what this could mean for delaying joint replacement. RESOURCES Article: Metformin for Knee Osteoarthritis in Patients With Overweight or Obesity: https://jamanetwork.com/journals/jama/article-abstract/2833338 CONNECT WITH US Twitter: @ProfDavidHunter @jointactionorg Instagram: @osteoarthritisresearchgroup Email: [email protected] Website: https://www.jointaction.info/podcast Hosted on Acast. See acast.com/privacy for more information.

In this episode of Joint Action, Professor David Hunter is joined by Dr. Stephanie Mathies and Dr. Giovanni Ferreira to unpack the cost-effectiveness of osteoarthritis treatments. They discuss the results of their recent systematic review, which analysed over 100 studies to identify which guideline-recommended treatments provide the best value for money. From exercise and medications to injections and surgery, they explore which interventions are truly cost-effective - and which may not be worth the spend. Learn why “simple things” like exercise and education still offer the most value, and what this means for patients, clinicians, and healthcare policy. RESOURCES Article: The cost-effectiveness of guideline-recommended treatments for osteoarthritis: A systematic review: https://www.oarsijournal.com/article/S1063-4584(25)00972-0/abstract CONNECT WITH US Twitter: @ProfDavidHunter @jointactionorg Instagram: @osteoarthritisresearchgroup Email: [email protected] Website: https://www.jointaction.info/podcast Hosted on Acast. See acast.com/privacy for more information.

In this week's episode of Joint Action, Professor David Hunter is joined by Dr Sarah Kobayashi, a lecturer in anatomy and osteoarthritis researcher, to talk about the power of walking - especially for people with osteoarthritis. Sarah shares her insights into the many health benefits of walking, why it’s so important for joint health, and how to overcome common barriers to getting started. She also introduces the CASCADE-OA study (Community bAsed phySical aCtivity AnD sElf-management for OsteoArthritis), a 12-month clinical trial exploring the effectiveness of a self-directed walking program, Walk With Ease Australia, in improving physical activity levels and managing symptoms for those with hip or knee osteoarthritis. Whether you're new to walking or looking to establish a sustainable routine, this episode offers practical advice and motivation to help you take that first step. RESOURCES Learn more about the CASCADE-OA study and check your eligibility: CASCADE-OA Study Overview: www.osteoarthritisresearch.com.au/cascadeoa-study-overview Ask your local arthritis organisation about Walk With Ease or the CASCADE-OA study: Arthritis Australia – www.arthritisaustralia.com.au/state-offices/ Additional resources: Versus Arthritis Walking Guide (UK): www.versusarthritis.org/about-arthritis/exercising-with-arthritis/exercises/walking Heart Foundation Walking Groups (Australia) – walking.heartfoundation.org.au Parkrun Australia: www.parkrun.com.au CONNECT WITH US Twitter: @ProfDavidHunter @jointactionorg Instagram: @osteoarthritisresearchgroup Email: [email protected] Website: www.jointaction.info/podcast Hosted on Acast. See acast.com/privacy for more information.

Running often gets a bad rap when it comes to knee osteoarthritis - but is the fear justified? In this week's episode of Joint Action, Professor David Hunter speaks with physiotherapist and researcher Dr Jean-François Esculier to unpack common myths about running and joint health. They explore the latest evidence, share tips for safe running with OA, and discuss how to build joint resilience over time. Tune in to learn why running might not just be safe - it could even be helpful. RESOURCES Education resource on running and joint health, in 7 languages: http://hdl.handle.net/2429/82767 CONNECT WITH US Twitter: @ProfDavidHunter @jointactionorg Instagram: @osteoarthritisresearchgroup Email: [email protected] Website: www.jointaction.info/podcast Hosted on Acast. See acast.com/privacy for more information.

High heels have long been associated with fashion - but what impact do they have on your joints? This week, Professor David Hunter is joined by physiotherapist and footwear researcher Dr. Kathryn Mills to unpack the biomechanics of high heels and their effect on knee health. From changes in posture and joint compression to the importance of shoe comfort and replacement, this episode blends science with practical advice for anyone managing knee pain or osteoarthritis. Plus, learn what to look for in a good shoe and when to seek professional help from a podiatrist or physiotherapist. RESOURCES Human Movement Montreal Instagram Page: https://www.instagram.com/humanmovementmontreal/ Australian Podiatry Association: https://www.podiatry.org.au/foot-health-resources/footwear-advice Australian Podiatry Association Fact Sheets: https://www.podiatry.org.au/foot-health-resources/footwear-health-check/footwear-health-check Australian Podiatry Association Fact Sheets: https://www.podiatry.org.au/foot-health-resources/incorrectly-fitted-shoes/incorrectly-fitted-shoes CONNECT WITH US Twitter: @ProfDavidHunter @jointactionorg Instagram: @osteoarthritisresearchgroup Email: [email protected] Website: www.jointaction.info/podcast Hosted on Acast. See acast.com/privacy for more information.

Can joint replacements reduce pain, help you move more - and live longer? In this week's podcast episode, we explore the untold benefits of hip and knee replacements beyond pain relief. Dr Tim Lindsay, clinician and researcher at Imperial College London, joins us to share insights from large-scale studies that show how joint replacement can restore physical activity levels and potentially reduce premature mortality. We also discuss why recovery takes time, how expectations should be managed, and what patients can realistically achieve after surgery. If you're considering joint replacement or supporting someone who is, this conversation offers evidence-based clarity and hope. RESOURCES ARTICLES Device-Measured Physical Activity in 3506 Individuals with Knee or Hip Arthroplasty: https://pubmed.ncbi.nlm.nih.gov/38109175 Wearable device measured physical activity and future health risk: https://www.nature.com/articles/s41591-020-1012-3 CONNECT WITH US Twitter: @ProfDavidHunter @jointactionorg Instagram: @osteoarthritisresearchgroup Email: [email protected] Website: www.jointaction.info/podcast Hosted on Acast. See acast.com/privacy for more information.

In this episode of Joint Action, Professor David Hunter is joined by Dr. Bruno da Costa, Associate Professor of Clinical Epidemiology at the University of Toronto and Senior Scientist at the University of Oxford, to unpack the evidence behind injections for osteoarthritis. Dr. da Costa shares insights from his recent systematic review and network meta-analysis of clinical trials, revealing just how limited - and at times unreliable - the evidence is for many joint injection therapies. This episode explores: Which injections (if any) offer real benefit - and for how long The surprising extent of bias in osteoarthritis trials Why some results may not be as credible as they seem The role of placebo effects and commercial influence What this means for people living with osteoarthritis If you’ve ever considered injection therapy, this episode will help you sort fact from fiction. RESOURCES S04E10 - Care for an oil change? The role of viscosupplementation for osteoarthritis wit Dr Bruno da Costa: https://www.jointaction.info/podcast/episode/6cda642b/care-for-an-oil-change-the-role-of-viscosupplementation-for-osteoarthritis-with-dr-bruno-da-costa Infographic - How effective are intra-articular interventions for osteoarthritis?: https://www.osteoarthritisresearch.com.au/s/0225-Clinical-Editors-Choice.png Article - Effectiveness and safety of intra-articular interventions for knee and hip osteoarthritis based on large randomized trials: A systematic review and network meta-analysis: https://www.oarsijournal.com/article/S1063-4584(24)01389-X/fulltext CONNECT WITH US Twitter: @ProfDavidHunter @jointactionorg Instagram: @osteoarthritisresearchgroup Email: [email protected] Website: www.jointaction.info/podcast Hosted on Acast. See acast.com/privacy for more information.

For too long, people living with osteoarthritis have felt powerless - like there’s nothing they can do to influence change. But that couldn’t be further from the truth. In this powerful episode, Prof. David Hunter is joined by Louise Hardy, Director of Policy and Advocacy at Arthritis Australia, to explore how individuals can use their voice to drive meaningful change - especially in the lead-up to the Australian federal election. Louise shares practical ways you can support better care, fairer funding, and more accessible services for the 7 million Australians living with arthritis. They discuss the importance of community-led advocacy, out-of-pocket costs, gaps in clinical care, and how you can be part of the solution, today. Whether you live in Australia or abroad, this episode offers a roadmap for how your voice can make a difference - starting now. RESOURCES Take action by emailing your local MP via the Arthritis Australia microsite: https://arthritisaus.good.do/election25/Act-Now-25/ Join the Arthritis Australia Champions program: https://arthritisaustralia.com.au/get-involved/arthritis-champions/ Learn more about Arthritis Australia initiatives: https://arthritisaustralia.com.au/ CONNECT WITH US Twitter: @ProfDavidHunter @jointactionorg Instagram: @osteoarthritisresearchgroup Email: [email protected] Website: www.jointaction.info/podcast Hosted on Acast. See acast.com/privacy for more information.

MRIs are increasingly used to detect early signs of osteoarthritis - but are they truly beneficial for most people? On this week's episode, we examine the role of MRI scans in diagnosing knee osteoarthritis, particularly in its early stages. Joined by leading experts Dr. Alison Chang, a professor of Physical Therapy at Northwestern University, and Dr. Ali Guermazi, a Radiology professor at Boston University, we explore the genuine value of MRIs. Our discussion highlights when these imaging tests can be helpful and when they might lead to unnecessary interventions. We also discuss why many MRI-detected changes don't actually progress into osteoarthritis and share practical advice for effectively managing knee health. Tune in for an evidence-based conversation to understand when MRIs truly add value - and when they may not. RESOURCES Learn more about the frequency of MRI-detected structural abnormalities in healthy, pain-free individuals: https://x.com/OACJournal/status/1843050098579943647 View the diagram illustrating Alison Chang’s 'inverted-U curve' concept of how activity levels relate to body capacity: Capacity vs. Load graphs_Dr Alison Chang.pdf CONNECT WITH US Twitter: @ProfDavidHunter @jointactionorg Instagram: @osteoarthritisresearchgroup Email: [email protected] Website: www.jointaction.info/podcast Hosted on Acast. See acast.com/privacy for more information.

What if you could know your risk of developing osteoarthritis years before symptoms appear? In this episode, we explore whether a blood test could provide those answers. Joining us on this week's episode is Dr. Virginia Kraus, a leading rheumatologist and researcher, to discuss her study that identified osteoarthritis risk up to 10 years in advance with 77% accuracy. We unpack what this means for early detection, the role of inflammation in disease progression, and how this research could shape future treatment and prevention strategies. Tune in to find out what the future of osteoarthritis detection could look like. RESOURCES The MOST Study: www.bumc.bu.edu/rheumatology/research/clinical-trials/the-multicenter-osteoarthritis-study-most/ CANTOS Trial: www.nejm.org/doi/full/10.1056/NEJMoa1707914 CONNECT WITH US Twitter: @ProfDavidHunter @jointactionorg Instagram: @osteoarthritisresearchgroup Email: [email protected] Website: www.jointaction.info/podcast Hosted on Acast. See acast.com/privacy for more information.

Menopause is often referred to as "the change" and remains a complex and sensitive topic for many. Despite being historically under-discussed, it's crucial to address because of its profound impact on musculoskeletal health. Women are two to three times more likely than men to develop osteoarthritis, particularly around menopause. Changes in hormones, such as declining estrogen, can affect cartilage, bone density, inflammation, muscle health, and body weight - factors closely linked to joint pain and osteoarthritis symptoms. In this episode of the Joint Action Podcast, Dr. Ginny Mansberg, a GP and women's health expert, joins Prof. David Hunter to explore the intricate relationship between menopause and osteoarthritis. They discuss the physical and emotional challenges women face, including sleep disruption, weight gain, joint pain, and mental health issues like anxiety and depression. Dr. Mansberg shares valuable insights into how hormone replacement therapy (HRT) and lifestyle strategies, including exercise, can help manage symptoms and improve long-term health outcomes. Whether you're navigating menopause or supporting someone who is, this episode offers a compassionate, evidence-informed perspective on understanding and managing the journey. RESOURCES Dr. Ginny Mansberg’s website: DrGini.com.au Dr. Ginny Mansberg's book - The M Word: How to Thrive in Menopause: https://drginni.com.au/products/the-m-word-how-to-thrive-in-menopause CONNECT WITH US Twitter: @ProfDavidHunter @jointactionorg Instagram: @osteoarthritisresearchgroup Email: [email protected] Website: www.jointaction.info/podcast Hosted on Acast. See acast.com/privacy for more information.

In this special episode of Joint Action, host Professor David Hunter brings together the most valuable insights from over 100 episodes, creating a practical guide to understanding and managing osteoarthritis. By summarising years of expert advice, groundbreaking research, and real-world strategies, this episode makes it easy to access the latest information on osteoarthritis in one comprehensive discussion. Key topics include: What osteoarthritis is, what causes it, and who it affects The role of exercise in reducing pain and improving mobility How diet impacts joint health, inflammation, and overall well-being Evidence on supplements, medications, and emerging therapies When surgery is appropriate and what options are available Holistic approaches to address both physical and emotional challenges Whether you’re newly diagnosed, managing osteoarthritis for years, or looking to prevent it, this episode provides essential, evidence-based insights to improve your quality of life. RESOURCES The ATLAS Study: www.osteoarthritisresearch.com.au/atlas-study-overview CONNECT WITH US Twitter: @ProfDavidHunter @jointactionorg Instagram: @osteoarthritisresearchgroup Email: [email protected] Website: www.jointaction.info/podcast Hosted on Acast. See acast.com/privacy for more information.

Join us for a unique and inspiring episode of the Joint Action podcast, where we step into a stylised clinical encounter between Professor Shannon Mihalko, acting as the clinician, and Tom Buttel, the patient. Together, they delve into the realities of living with osteoarthritis, sharing powerful insights into overcoming challenges, setting meaningful goals, and adopting holistic management strategies. From the importance of building a strong relationship with your healthcare team to Tom's personal tips for staying active, managing pain, and fostering self-compassion, this episode is packed with practical advice and relatable moments. Whether you're looking to better manage your joint health or simply find inspiration in someone else's journey, this conversation is not to be missed. Tune in and discover how small, sustainable changes can lead to lasting health benefits. RESOURCES The Osteoarthritis Prevention Study (TOPS study): www.osteoarthritisresearch.com.au/tops-study-overview CONNECT WITH US Twitter: @ProfDavidHunter @jointactionorg Instagram: @osteoarthritisresearchgroup Email: [email protected] Website: www.jointaction.info/podcast Hosted on Acast. See acast.com/privacy for more information.

Welcome to Season 6 of the Joint Action Podcast and the first episode of 2025! We're kicking off with a crucial topic in advancing osteoarthritis treatment: understanding clinical trials. Clinical trials are vital for developing new treatments for osteoarthritis, yet many people are mystified by the process. Why participate? What are the benefits? What are the risks? In this episode, we break it all down with Dr. Karen Bracken, Clinical Trial Program Lead at the Kolling Institute, University of Sydney. With over 20 years of experience managing clinical trials, Karen provides an insider’s perspective on the motivations, processes, and considerations involved in clinical research. Join us as we explore: The potential benefits of participating in clinical trials, such as access to new treatments and contributing to science. Key considerations, including time commitments and informed consent. How clinical trials are designed to prioritise participant safety and generate reliable evidence. Misconceptions about clinical trials and how they differ from reality. We also discuss exciting ongoing trials, including the ATLAS study for knee osteoarthritis, the TOPS osteoarthritis prevention study, and the MARVEL study exploring the impact of pentosan polysulfate sodium on knee pain. Whether you're curious about clinical trials or considering participating in one, this episode offers valuable insights to guide your journey. RESOURCES To learn more about osteoarthritis clinical trials, visit our website: www.osteoarthritisresearch.com.au To learn more about the Osteoarthritis Research Participant Network or to join, click here: www.osteoarthritisresearch.com.au/oa-participant-network Current osteoarthritis studies: The ATLAS study: www.osteoarthritisresearch.com.au/atlas-study-overview TOPS study: www.osteoarthritisresearch.com.au/tops-study-overview The MaRVeL study: www.osteoarthritisresearch.com.au/marvel-study-overview Previous podcast episodes S05E05 - Core outcome sets for osteoarthritis trials with Prof. Toby Smith Websites OMERACT - Outcome Measures in Rheumatology: www.omeract.org Hosted on Acast. See acast.com/privacy for more information.